Press releases

Regulatory press release 2021-05-06

Xspray Pharma publishes Interim Report Q1, January – March 2021

Regulatory press release 2021-04-20

Notice of annual general meeting of Xspray Pharma AB (publ)

Press release 2021-04-08

Xspray Pharma announces update of its improved version of dasatinib

Regulatory press release 2021-04-08

Xspray Pharma announces the results of two bioequivalence studies with adjusted tablet formulation of HyNap-Dasa (ANDA)

Regulatory press release 2021-03-19

Xspray Pharma publishes its annual report for 2020

All press releases

Latest report
Interim Report Q1 2021
Subscribe
Get our latest press releases and reports
Subscribe
Submit to our press releases and get an email every time we publish a press release or report on our website.
Type*
Reports
Press releases
E-mail*

Välj språk*
Swedish
English
When clicked on Send I agree that my personal information will be saved. Read more
Name
This field is for validation purposes and should be left unchanged.

Press contact

Per Andersson, CEO

+46 (0)8 730 37 00

per.andersson@xspray.com

Presentations and interviews

Presentation of Xspray Pharma at Redeye Orphan Drug Seminar, April 28, 2020

Interview with Per Andersson at Redeye, April 9, 2021

Interview with CEO Per Andersson at Direkt Studios, 21 January 2021

Media